$SRNE Production, Volume & Capacity VS all of the other companies - Very Important Point - "Our Antibody is VERY Potent" - 20,000 doses per run - Regeneron has do 2 runs in order to produce one antibody. FDA regulates the antibody productions - The go on their own timeline... Enrollment proof of concept is weeks, not months - Anvisa in Brazil. MULTIPLE GLOBAL WAVES of this virus. This was a great call regardless of the stock price, I never invested to sell on hype anyways, I am here until its $100 a share or bought out. Covid and Cancer are here to stay and the whole world needs cures for both.
  • 1
1 Like